APA (7th ed.) Citation

AN, P., MD, H., SB, S., J, K., J, A., P, R., . . . M, P. (2025). Dynamic choice HIV prevention with long-acting injectable cabotegravir pre-exposure prophylaxis in east, central, southern, and west Africa: A cost-effectiveness modelling analysis. The lancet. HIV, 12(10), e701. https://doi.org/10.1016/S2352-3018(25)00169-9

Chicago Style (17th ed.) Citation

AN, Phillips, et al. "Dynamic Choice HIV Prevention with Long-acting Injectable Cabotegravir Pre-exposure Prophylaxis in East, Central, Southern, and West Africa: A Cost-effectiveness Modelling Analysis." The Lancet. HIV 12, no. 10 (2025): e701. https://doi.org/10.1016/S2352-3018(25)00169-9.

MLA (9th ed.) Citation

AN, Phillips, et al. "Dynamic Choice HIV Prevention with Long-acting Injectable Cabotegravir Pre-exposure Prophylaxis in East, Central, Southern, and West Africa: A Cost-effectiveness Modelling Analysis." The Lancet. HIV, vol. 12, no. 10, 2025, p. e701, https://doi.org/10.1016/S2352-3018(25)00169-9.